Morgan Stanley Kodiak Sciences Inc. Transaction History

Morgan Stanley

$1.36 Trillion
Q1 2025

A detailed history of Morgan Stanley transactions in Kodiak Sciences Inc. stock. As of the latest transaction made, Morgan Stanley holds 453,833 shares of KOD stock, worth $1.62 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

453,833

Previous 339,238 33.78%

Holding current value

$1.62 Million

Previous $3.38 Million 62.22%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$2.81 - $9.57 $322,011 - $1.1 Million	114,595 Added 33.78%	453,833 $1.28 Million
Q4 2024 Feb 14, 2025	SELL	$2.6 - $10.9 $57,072 - $239,265	-21,951 Reduced 6.08%	339,238 $3.38 Million
Q3 2024 May 14, 2025	SELL	$2.2 - $3.25 $97,004 - $143,302	-44,093 Reduced 10.88%	361,189 $942,000
Q3 2024 Nov 14, 2024	SELL	$2.2 - $3.25 $97,004 - $143,302	-44,093 Reduced 10.88%	361,189 $942,000
Q2 2024 May 14, 2025	BUY	$2.29 - $4.48 $151,240 - $295,877	66,044 Added 19.47%	405,282 $952,000
Q2 2024 Oct 17, 2024	SELL	$2.29 - $4.48 $1.15 Million - $2.26 Million	-503,569 Reduced 55.41%	405,282 $952,000
Q2 2024 Aug 14, 2024	SELL	$2.29 - $4.48 $1.15 Million - $2.26 Million	-503,569 Reduced 55.41%	405,282 $952,000
Q1 2024 Oct 17, 2024	BUY	$3.01 - $7.45 $1.52 Million - $3.75 Million	503,569 Added 124.25%	908,851 $4.78 Million
Q1 2024 Aug 16, 2024	BUY	$3.01 - $7.45 $2.04 Million - $5.05 Million	678,255 Added 294.13%	908,851 $4.78 Million
Q1 2024 May 15, 2024	BUY	$3.01 - $7.45 $2.04 Million - $5.05 Million	678,255 Added 294.13%	908,851 $4.78 Million
Q4 2023 Aug 16, 2024	SELL	$1.4 - $3.24 $244,560 - $565,982	-174,686 Reduced 43.1%	230,596 $701,000
Q4 2023 Feb 13, 2024	BUY	$1.4 - $3.24 $20,084 - $46,481	14,346 Added 6.63%	230,596 $701,000
Q3 2023 Nov 15, 2023	SELL	$1.8 - $7.49 $92,142 - $383,413	-51,190 Reduced 19.14%	216,250 $389,000
Q2 2023 Aug 14, 2023	SELL	$4.3 - $9.48 $1.18 Million - $2.6 Million	-273,856 Reduced 50.59%	267,440 $1.85 Million
Q1 2023 May 15, 2023	SELL	$4.81 - $8.88 $1.06 Million - $1.95 Million	-219,804 Reduced 28.88%	541,296 $3.36 Million
Q4 2022 Feb 14, 2023	SELL	$6.52 - $8.05 $801,425 - $989,489	-122,918 Reduced 13.9%	761,100 $5.45 Million
Q3 2022 Nov 14, 2022	SELL	$7.57 - $12.5 $500,649 - $826,700	-66,136 Reduced 6.96%	884,018 $6.84 Million
Q2 2022 Oct 27, 2022	SELL	$5.04 - $9.48 $2.09 Million - $3.93 Million	-414,179 Reduced 30.36%	950,154 $7.26 Million
Q2 2022 Aug 15, 2022	SELL	$5.04 - $9.48 $2.09 Million - $3.93 Million	-414,179 Reduced 30.36%	950,154 $7.26 Million
Q1 2022 Oct 27, 2022	BUY	$7.09 - $89.45 $2.94 Million - $37 Million	414,179 Added 43.59%	1,364,333 $10.5 Million
Q1 2022 May 13, 2022	BUY	$7.09 - $89.45 $7.88 Million - $99.4 Million	1,111,681 Added 440.0%	1,364,333 $10.5 Million
Q4 2021 Feb 14, 2022	SELL	$80.85 - $128.49 $498,116 - $791,626	-6,161 Reduced 2.38%	252,652 $21.4 Million
Q3 2021 Nov 15, 2021	BUY	$81.97 - $106.94 $21.2 Million - $27.7 Million	258,813 New	258,813 $24.8 Million

Others Institutions Holding KOD

# of Institutions

109

Shares Held

41.8M

Call Options Held

10.9K

Put Options Held

700

View Full List

About Kodiak Sciences Inc.

Ticker KOD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,040,200
Market Cap $186M
Description
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...

More about KOD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account